These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16275982)

  • 1. Letter re: 25-OH-vitamin D assays.
    Fradinger EE
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6337-8; author reply 6338. PubMed ID: 16275982
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vitamin D supplements. Recommended doses are not enough].
    Díez Pérez A
    Med Clin (Barc); 2012 Mar; 138(5):202-3. PubMed ID: 22197369
    [No Abstract]   [Full Text] [Related]  

  • 3. Ten years of alendronate treatment for osteoporosis in postmenopausal women.
    Chan AS
    N Engl J Med; 2004 Jul; 351(2):190-2; author reply 190-2. PubMed ID: 15250065
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer.
    Nogues X; Servitja S; Peña MJ; Prieto-Alhambra D; Nadal R; Mellibovsky L; Albanell J; Diez-Perez A; Tusquets I
    Maturitas; 2010 Jul; 66(3):291-7. PubMed ID: 20399042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
    Fuller KE
    N Engl J Med; 2004 Jan; 350(2):189-92; author reply 189-92. PubMed ID: 14714278
    [No Abstract]   [Full Text] [Related]  

  • 6. Alendronate and parathyroid hormone.
    Muldowney FP
    N Engl J Med; 2005 Dec; 353(24):2618-9; author reply 2618-9. PubMed ID: 16354902
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relationship between vitamin D status and bone mineral density in Croatian postmenopausal women].
    Laktasić-Zerjavić N; Rukavina K; Babić-Naglić D; Curković B; Anić B; Soldo-Juresa D
    Reumatizam; 2013; 60(1):8-13. PubMed ID: 24003677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitamin D status in osteoporotic postmenopausal women taking oral recommended vitamin D supplementation].
    Ivorra J; Valls E; Fernández-Llanio Comella N; Chalmeta Verdejo I; Oliver Oliver MJ; Román Ivorra JA
    Med Clin (Barc); 2012 Mar; 138(5):199-201. PubMed ID: 22197363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of vitamin D insufficiency with combined strontium ranelate and vitamin D3 in osteoporotic patients.
    Rizzoli R; Dawson-Hughes B; Kaufman JM; Fardellone P; Brandi ML; Vellas B; Collette J; Reginster JY
    Eur J Endocrinol; 2014 Mar; 170(3):441-50. PubMed ID: 24322182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.
    Amouzougan A; Deygat A; Trombert B; Constant E; Denarié D; Marotte H; Thomas T
    Osteoporos Int; 2015 Dec; 26(12):2869-75. PubMed ID: 26104797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D status, dependence on age, and seasonal variations in the concentration of vitamin D in Croatian postmenopausal women initially screened for osteoporosis.
    Laktasic-Zerjavic N; Korsic M; Crncevic-Orlic Z; Kovac Z; Polasek O; Soldo-Juresa D
    Clin Rheumatol; 2010 Aug; 29(8):861-7. PubMed ID: 20204667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal osteoporosis.
    Chan AS
    N Engl J Med; 2005 Nov; 353(18):1974-5. PubMed ID: 16267333
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence and predictors of vitamin D inadequacy amongst Lebanese osteoporotic women.
    Gannagé-Yared MH; Maalouf G; Khalife S; Challita S; Yaghi Y; Ziade N; Chalfoun A; Norquist J; Chandler J
    Br J Nutr; 2009 Feb; 101(4):487-91. PubMed ID: 18631414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.
    Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ
    Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women with insufficient 25-hydroxyvitamin D without secondary hyperparathyroidism have altered bone turnover and greater incidence of vertebral fractures.
    Ikegami S; Kamimura M; Uchiyama S; Kato H
    J Orthop Sci; 2011 Sep; 16(5):573-80. PubMed ID: 21713425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin D deficiency in postmenopausal women receiving osteoporosis therapy].
    Kraljević I; Kastelan D; Gorsić I; Solak M; Giljević Z; Kasović M; Sertić J; Korsić M
    Lijec Vjesn; 2007; 129(8-9):304. PubMed ID: 18198632
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy.
    Holick MF; Siris ES; Binkley N; Beard MK; Khan A; Katzer JT; Petruschke RA; Chen E; de Papp AE
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3215-24. PubMed ID: 15797954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing loss in postmenopausal women with low bone mineral density.
    Kim JY; Lee SB; Lee CH; Kim HM
    Auris Nasus Larynx; 2016 Apr; 43(2):155-60. PubMed ID: 26277375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D status and response to daily 400 IU vitamin D3 and weekly alendronate 70 mg in men and women with osteoporosis.
    Karaplis AC; Chouha F; Djandji M; Sampalis JS; Hanley DA
    Ann Pharmacother; 2011 May; 45(5):561-8. PubMed ID: 21521859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D insufficiency together with high serum levels of vitamin A increases the risk for osteoporosis in postmenopausal women.
    Mata-Granados JM; Cuenca-Acevedo JR; Luque de Castro MD; Holick MF; Quesada-Gómez JM
    Arch Osteoporos; 2013; 8():124. PubMed ID: 23417776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.